Last November, JDRF officials announced that researchers had found biological markers for Type 1 diabetes long before symptoms appeared in children. Now another group of researchers hope to see if they can prevent Type 1 before children become symptomatic, and to do it they are planning to use a classic tool in diabetes management – […]
ViaCyte, a leader in stem cell therapies for diabetes, is conducting this first human trial of its kind. And a husband/wife team is producing the first documentary of its kind. They are filming the trial results as they occur.
People with Type 1 are not immune from obesity, and some turn to bariatric surgery. However, researchers from the Cleveland Clinic found that 25 percent of those with Type 1 who received this surgery suffered from moderate to severe diabetic ketoacidosis (DKA) afterwards.
Podiatrists and vascular experts recently developed new diabetic foot management guidelines, according to a Medscape report. Recommendations focus on preventing and relieving major foot issues that can come with diabetes. Here are some highlights of what they recommended.
One of the first devices to hit the market is Sensus, by NeuroMetrix. Available by prescription, it relies on external electrical stimulation of nerves and nerve pathways to lessen and control DPN pain in the feet and legs. The device is designed to wrap around the calf under your clothes, and is secured by a […]
Dexcom and Medtronic’s recent quarterly update calls shared new timing details on their latest continuous glucose monitoring (CGM) products – our team listens to all these calls and we wanted to give you a “what’s what!” update. Read below for specifics on the CGM upgrades, which will improve the experience of wearing CGM on many […]
JDRF and Sanofi have announced a $4.6 million, three-year initiative to expand development of insulins that require fewer injections and dermal patch-delivered insulin. In both cases, it’s hoped that the insulin delivered will be able to respond automatically to changes in blood sugar levels and other body metabolism signals.
As with all type 1 diabetes cure research, a solution to the particular problem of encapsulation is elusive and still years (decades?) away. But despite the long timeline and the many hurdles still to be crossed before this material could potentially be used in a clinical setting, Vegas’s enthusiasm for the project is palpable.
A recent study found that metformin might help overweight teens with Type 1 diabetes lower their A1C scores. Metformin, an oral medication that’s prescribed to treat Type 2 diabetes, helped the teens lower their insulin resistance.
The meeting provided the opportunity to hear from leading JDRF physicians and researchers about progress on everything from the artificial pancreas to islet cell replacement therapy to efforts in prevention. All in all, the two-day event was a remarkable opportunity to see firsthand how JDRF is driving progress in all areas of type 1 diabetes […]
Study researchers believe they have found that the liver of a person with Type 1 may produce an excessive amount of a protein that can hamper digestion, according to a Science Daily report.
Dr. Melton’s research group attracted a great deal of excitement in 2014 when it published a way of producing large quantities of insulin-producing cells from human stem cells. These cells successfully normalized blood glucose when implanted in rodents, but only those without a functioning immune system.
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They’ve already begun testing it in a small number of diabetic patients. If it works as well in patients […]
The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
The number of people newly diagnosed with diabetes continues to decline after decades of increases that transformed what was once a disease of the old into a public health crisis that affects even children.
For people with diabetes, fear can be especially dangerous. Make no mistake, this disease is scary. Both type 1s and type 2s face an array of worrying side effects, both from the condition itself and from the ways we have to treat it.
A new study has shown that adults with diabetic peripheral neuropathy (DPN) are at greater risk of falling during day-to-day activities; this is because they are more likely to have impaired balance.
There is no right or wrong way to manage your diabetes. With that being said, there are a variety of options and devices that can be used for proper diabetes management.
In a study published in Cell, Host & Microbe earlier this year, the largest longitudinal study of the microbiome to date, researchers saw dramatic shifts in the gut bacteria of children who went on to develop type 1 diabetes. The study could have important implications for identifying the disease at a very early stage, delaying […]
Researchers in the UK found that an experimental closed-loop artificial pancreas system did better than humans alone at managing Type 1 diabetes, according to a Reuters report. The closed-loop software, which could be turned on and off at will, included a glucose sensor and insulin pump that sent wireless signals every 12 minutes to adjust […]